Sale

Anaesthesia Drugs Market

Global Anaesthesia Drugs Market Size, Share, Trends, Report: By Type: General Anaesthesia Drugs, Local Anaesthesia Drugs; By Route of Administration: Inhalation, Intravenous, Topical; By Application: General Surgery, Heart Surgery, Others; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Anaesthesia Drugs Market Outlook

The global anaesthesia drugs market stood at a value of nearly USD 6.08 billion in 2023. The market is further expected to grow at a CAGR of 4.2% in the forecast period of 2024-2032 to attain a value of almost USD 8.81 billion by 2032.

 

Anaesthesia Drugs Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Use of Local Drugs to Augment the Global Anaesthesia Drugs Industry

On the basis of drug type, the local drug segment accounted for a significant share in the market and is anticipated to witness a steady growth over the forecast period. The growth can be attributed to the rising demand for local drugs in various applications, particularly dental surgeries. The anticipated increase in minor procedures such as filling or wisdom tooth removal is expected to bolster the demand for local anaesthetics. Meanwhile, the growing awareness about the benefits of general drugs, which include reduced intraoperative patient awareness and complete control of the airway, breathing and circulation, among others, is expected to aid the growth of the segment.

 

Based on the route of administration, the inhalation segment is likely to account for a significant share in the market owing to the cost-effectiveness of the method and its precise control over the anaesthetic state. Also, the inhaled anaesthetics have a low solubility in the blood and tissues, possess a protective effect and are resistant to physical and metabolic degradation, thus, further contributing to the demand growth.

 

North America Accounts for a Significant Share in the Global Anaesthesia Drugs Industry

North America, due to rapid technological advancements and the high healthcare expenditure, accounts for a considerable share in the market. The region is further expected to be aided by the increasing number of surgeries in countries like the United States and Canada. Meanwhile, Europe and the Asia Pacific are likely to grow at a significant rate in the forecast period owing to the ongoing healthcare reforms in the regions. The increasing focus to improve access to healthcare facilities in emerging countries of the Asia Pacific is expected to significantly contribute to the market growth in the forecast period.

 

Anaesthesia Drugs: Market Segmentation

Anaesthesia can be defined as the use of medicines to prevent pain during a medical procedure. Thus, the combination of medications that put a person in a sleep-like state before a surgery or some other medical procedure is known as anaesthetic drug. Anaesthetic drugs are used to ensure that a patient is in a completely unconscious state so that he/she does not feel any kind of pain.

 

Global Anaesthesia Drugs Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on route of administration, the market is divided into:

  • Inhalation
  • Injection
  • Others

 

On the basis of drug type, the industry is segmented into:

  • General Drug
  • Local Drug

 

While the general drug segment is further divided into propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others, the local drug segment is further categorised into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others.

 

The significant applications of the product are:

  • General Surgery
  • Plastic Surgery
  • Cosmetic Surgery
  • Dental Surgery
  • Others

 

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Anaesthesia Drugs Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Prevalence of Gastrointestinal Diseases to Boost the Growth of the Anaesthesia Drugs Industry

The global anaesthesia drugs industry is driven by the rising prevalence of gastrointestinal diseases, such as gastroesophageal disease, liver cirrhosis, pancreatitis, and inflammatory bowel disease, among others. These diseases require intense surgery to attack the root of the disease, therefore, appropriate anaesthesia is needed for the safety of the patients. In addition, the easy availability of local drugs and the increasing hospitalisation rates are significantly contributing to the market growth. Over the forecast period, the market is expected to be aided by the rapid advancements in the healthcare industry.

 

Key Industry Players in the Global Anaesthesia Drugs Market

The report gives a detailed analysis of the following key players in the global anaesthesia drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

 

  • Pfizer Inc.
  • Fresenius SE & Co. KGaA
  • Baxter International, Inc.
  • AbbVie Inc.
  • B. Braun Melsungen AG
  • Piramal Enterprises Limited
  • Others

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Route of Administration
  • Application
  • End User
  • Distribution Channel
  • Region
Breakup by Type
  • General Anaesthesia Drugs
  • Local Anaesthesia Drugs
Breakup by Route of Administration
  • Inhalation
  • Intravenous
  • Topical
Breakup by Application
  • General Surgery
  • Heart Surgery
  • Plastic Surgery
  • Cosmetic Surgery
  • Dental Surgery
  • Hair Transplant Surgery
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Dental Clinics
  • Ambulatory Surgical Centres
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Apotex Inc.
  • Aspen Pharmacare Holdings Limited
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Braun Melsungen AG
  • Claris Lifesciences Limited
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Novartis AG
  • Pacira Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Piramal Enterprises LTD.
  • Septodont Healthcare India Pvt. Ltd.
  • Teva Pharmaceutical Industries Limited
  • Sanofi
  • Takeda Pharmaceutical Company Limited
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Anaesthesia Drugs Market Overview 

    3.1    Global Anaesthesia Drugs Market Historical Value (2017-2023) 
    3.2    Global Anaesthesia Drugs Market Forecast Value (2024-2032)
4    Global Anaesthesia Drugs Market Landscape
    4.1    Global Anaesthesia Drugs Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Anaesthesia Drugs Product Landscape
        4.2.1    Analysis by Drug Type
        4.2.2    Analysis by Route of Administration
        4.2.3    Analysis by Applications
5    Global Anaesthesia Drugs Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Anaesthesia Drugs Market Segmentation 
    6.1    Global Anaesthesia Drugs Market by Type
        6.1.1    Market Overview
        6.1.2    General Anaesthesia Drugs
            6.1.2.1    Propofol
            6.1.2.2    Sevoflurane
            6.1.2.3    Desflurane
            6.1.2.4    Dexmedetomidine
            6.1.2.5    Remifentanil
            6.1.2.6    Midazolam
            6.1.2.7    Others
        6.1.3    Local Anaesthesia Drugs
            6.1.3.1    Bupivacaine
            6.1.3.2    Ropivacaine
            6.1.3.3    Lidocaine
            6.1.3.4    Chloroprocaine
            6.1.3.5    Prilocaine
            6.1.3.6    Benzocaine
            6.1.3.7    Others
    6.2    Global Anaesthesia Drugs Market by Route of Administration
        6.2.1    Market Overview
        6.2.2    Inhalation
        6.2.3    Intravenous
        6.2.4    Topical
    6.3    Global Anaesthesia Drugs Market by Application
        6.3.1    Market Overview
        6.3.2    General Surgery
        6.3.3    Heart Surgery
        6.3.4    Plastic Surgery
        6.3.5    Cosmetic Surgery
        6.3.6    Dental Surgery
        6.3.7    Hair Transplant Surgery
        6.3.8    Other Applications
    6.4    Global Anaesthesia Drugs Market by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Specialty Clinics
        6.4.4    Dental Clinics
        6.4.5    Ambulatory Surgical Centres
        6.4.6    Others
    6.5    Global Anaesthesia Drugs Market by Distribution Channel
        6.5.1    Market Overview
        6.5.2    Hospital Pharmacy
        6.5.3    Retail Pharmacy
        6.5.4    Online Pharmacy
        6.5.5    Others
    6.6    Global Anaesthesia Drugs Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Anaesthesia Drugs Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Anaesthesia Drugs Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Anaesthesia Drugs Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Anaesthesia Drugs Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Anaesthesia Drugs Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Apotex Inc.
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisition
        17.1.5    Certifications
    17.2    Aspen Pharmacare Holdings Limited
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisition
        17.2.5    Certifications
    17.3    Baxter International Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisition
        17.3.5    Certifications
    17.4    Boehringer Ingelheim International GmbH
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisition
        17.4.5    Certifications
    17.5    Braun Melsungen AG
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisition
        17.5.5    Certifications
    17.6    Claris Lifesciences Limited
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisition
        17.6.5    Certifications
    17.7    Eisai Co. Ltd.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisition
        17.7.5    Certifications
    17.8    F. Hoffmann-La Roche Ltd.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisition
        17.8.5    Certifications
    17.9    Fresenius SE & Co. KGaA
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisition
        17.9.5    Certifications
    17.10    Hikma Pharmaceuticals PLC
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisition
        17.10.5    Certifications
    17.11    Novartis AG
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisition
        17.11.5    Certifications
    17.12    Pacira Pharmaceuticals, Inc.
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisition
        17.12.5    Certifications
    17.13    Pfizer Inc.
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisition
        17.13.5    Certifications
    17.14    Piramal Enterprises LTD.
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisition
        17.14.5    Certifications
    17.15    Septodont Healthcare India Pvt. Ltd.
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisition
        17.15.5    Certifications
    17.16    Teva Pharmaceutical Industries Limited
        17.16.1    Financial Analysis
        17.16.2    Product Portfolio
        17.16.3    Demographic Reach and Achievements
        17.16.4    Mergers and Acquisition
        17.16.5    Certifications
    17.17    Sanofi
        17.17.1    Financial Analysis
        17.17.2    Product Portfolio
        17.17.3    Demographic Reach and Achievements
        17.17.4    Mergers and Acquisition
        17.17.5    Certifications
    17.18    Takeda Pharmaceutical Company Limited
        17.18.1    Financial Analysis
        17.18.2    Product Portfolio
        17.18.3    Demographic Reach and Achievements
        17.18.4    Mergers and Acquisition
        17.18.5    Certifications
18    Global Anaesthesia Drugs Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global anaesthesia drugs market attained a volume of nearly USD 6.08 Billion.

The market is estimated to grow at a CAGR of 4.2% in the forecast period of 2024-2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 8.81 billion by 2032.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Inhalation, and injection, among others are the different routes of administration of the product.

General drug (propofol, sevoflurane, desflurane, dexmedetomidine, remifentanil, midazolam, and others) and local drug (bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and others) are the different drug types of the product.

General Surgery, Heart Surgerie, Plastic Surgery, Cosmetic Surgery, Dental Surgery and Hair Transplant Surgery, among others are the significant applications of the products.

The major players in the industry are F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Novartis AG, Pacira Pharmaceuticals, Inc., Pfizer Inc. and among others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER